Liraglutide vs Tirzepatide

Liraglutide (brand names Saxenda and Victoza) is a GLP-1 receptor agonist approved to treat type 2 diabetes, obesity, and cardiovascular risk reduction. Tirzepatide (brand names Mounjaro and Zepbound) is a dual GIP and GLP-1 receptor agonist approved for type 2 diabetes, obesity, and obstructive sleep apnea. The main practical difference is that liraglutide is taken as a daily injection, while tirzepatide is taken as a weekly injection.

AI summary of the sources below.